Nemaura Medical surges on purchase order for glucose monitor

Nemaura Medical

05/05/2021 15:15

** Shares of the medical device maker  NMRD.O  jump 40% to
$6.58
    ** Co receives purchase order for 5,000 sugarBEAT
transmitters and 200,000 sugarBEAT sensors from its UK licensee,
DB Ethitronix Ltd  urn:newsml:reuters.com:*:nGNX376nm3
    ** sugarBEAT is the company's non-invasive and flexible
continuous glucose monitor
    ** Agreement includes additional rolling monthly purchase
order forecast for next 24 months of 15,000 transmitters and 2.1
million sensors
    ** Order follows positive feedback from the soft launch of
glucose monitoring device in UK - co
    ** NMRD is advancing discussions for joint launches in
Germany, Saudi Arabia and UAE

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))